In the Matter of Universal Medical Systems, Inc.; Order of Suspension of Trading, 32379 [06-5128]

Download as PDF Federal Register / Vol. 71, No. 107 / Monday, June 5, 2006 / Notices 397–4209 or (301) 415–4737, or by email to pdr@nrc.gov. Dated at Rockville, Maryland, this 24th day of May, 2006. For the Nuclear Regulatory Commission. Stewart W. Brown, Sr. Project Manager, Spent Fuel Project Office, Office of Nuclear Material Safety and Safeguards. [FR Doc. E6–8650 Filed 6–2–06; 8:45 am] BILLING CODE 7590–01–P SECURITIES AND EXCHANGE COMMISSION [File No. 500–1] In the Matter of Universal Medical Systems, Inc.; Order of Suspension of Trading June 1, 2006. It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of Universal Medical Systems, Inc. (n/k/a Moray Way Holdings, Inc.) because it has not filed any periodic reports since it filed a Form 10–SB registration statement on April 24, 1997. The Commission is of the opinion that the public interest and the protection of investors require a suspension of trading in the securities of the above-listed company. Therefore, it is ordered, pursuant to section 12(k) of the Securities Exchange Act of 1934, that trading in the abovelisted company is suspended for the period from 9:30 a.m. EDT on June 1, 2006, through 11:59 p.m. EDT on June 14, 2006. By the Commission. Nancy M. Morris, Secretary. [FR Doc. 06–5128 Filed 6–1–06; 11:37 am] BILLING CODE 8010–01–P SECURITIES AND EXCHANGE COMMISSION cprice-sewell on PROD1PC66 with NOTICES [Release No. 34–53880; File No. SR–Amex– 2006–51] Self-Regulatory Organizations; American Stock Exchange LLC; Notice of Filing and Immediate Effectiveness of Proposed Rule Change To Adopt an Options Licensing Fee for Options on Market Vectors-Gold Miners ExchangeTraded Fund I. Self-Regulatory Organization’s Statement of the Terms of Substance of the Proposed Rule Change Amex proposes to modify its Options Fee Schedule by adopting a per-contract license fee for the orders of specialists, registered options traders, firms, nonmember market makers, and brokerdealers (collectively, ‘‘Market Participants’’) in connection with options transactions on the shares of the Market Vectors-Gold Miners exchangetraded fund (symbol: GDX). The text of the proposed rule change is available on the Exchange’s Internet Web site http://www.amex.com, at the Exchange’s principal office, and at the Commission’s Public Reference Room. II. Self-Regulatory Organization’s Statement of the Purpose of, and Statutory Basis for, the Proposed Rule Change In its filing with the Commission, the Exchange included statements concerning the purpose of, and basis for, the proposed rule change and discussed any comments it received on the proposed rule change. The text of these statements may be examined at the places specified in Item IV below. The Exchange has prepared summaries, set forth in Sections A, B, and C below, of the most significant aspects of such statements. A. Self-Regulatory Organization’s Statement of the Purpose of, and Statutory Basis for, the Proposed Rule Change 1. Purpose The purpose of the proposal is to adopt a per-contract options licensing Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934 15:33 Jun 02, 2006 Jkt 208001 U.S.C. 78s(b)(1). CFR 240.19b–4. 3 15 U.S.C. 78s(b)(3)(A)(ii). 4 17 CFR 240.19b–4(f)(2). fee in connection with options on GDX. Amex represents that it plans to assess the proposed options licensing fee on members commencing May 22, 2006. The Exchange has entered into numerous agreements with various index providers for the purpose of trading options on certain exchangetraded funds (‘‘ETFs’’) such as GDX. As a result, the Exchange is required to pay index license fees to third parties as a condition to the listing and trading of these ETF options. In many cases, the Exchange is required to pay a significant licensing fee to the index provider that may not be reimbursed. In an effort to recoup the costs associated with certain index licenses, the Exchange has recently established per-contract licensing fees for orders of Market Participants that are collected on each option transaction in certain designated products in which such Market Participant is a party.5 The purpose of the proposal, therefore, is to charge an options licensing fee in connection with options on the GDX. Specifically, Amex seeks to charge an options licensing fee of $0.05 per contract side for GDX options for Market Participant orders executed on the Exchange. In all cases, the fee would be charged only to the Exchange member through whom such order is placed. Amex represents that the proposed options licensing fees would allow the Exchange to recoup its costs in connection with the index license fees for the trading of GDX options. The fees would be collected on every Market Participant order executed on the Exchange. The Exchange believes that requiring the payment of a per-contract licensing fee in connection with GDX options by those Market Participants that benefit from the index license agreements is justified and consistent with the rules of the Exchange. The Exchange notes that, in recent years, it has revised a number of its fees to better align Amex fees with the actual cost of delivering services and reduce Amex’s subsidization of such services. The Exchange believes that the implementation of this proposal is consistent with the reduction and/or elimination of these subsidies. Amex believes that these fees will help to allocate to those Market Participants engaging in transactions in GDX options a fair share of the related costs of offering such options for trading. The Exchange asserts that the proposal provides for an equitable 1 15 May 26, 2006. VerDate Aug<31>2005 (‘‘Act’’) 1 and Rule 19b–4 thereunder,2 notice is hereby given that on May 19, 2006, the American Stock Exchange LLC (‘‘Amex’’ or ‘‘Exchange’’) filed with the Securities and Exchange Commission (‘‘Commission’’) the proposed rule change as described in Items I, II, and III below, which Items have been prepared by the Exchange. Amex has designated this proposal as one establishing or changing a due, fee, or other charge imposed by a selfregulatory organization pursuant to Section 19(b)(3)(A)(ii) of the Act 3 and Rule 19b–4(f)(2) thereunder,4 which renders the proposal effective upon filing with the Commission. The Commission is publishing this notice to solicit comments on the proposed rule change from interested persons. 32379 2 17 PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 5 See Securities Exchange Act Release No. 52493 (September 22, 2005), 70 FR 56941 (September 29, 2005). E:\FR\FM\05JNN1.SGM 05JNN1

Agencies

[Federal Register Volume 71, Number 107 (Monday, June 5, 2006)]
[Notices]
[Page 32379]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-5128]


=======================================================================
-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[File No. 500-1]


In the Matter of Universal Medical Systems, Inc.; Order of 
Suspension of Trading

June 1, 2006.
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
Universal Medical Systems, Inc. (n/k/a Moray Way Holdings, Inc.) 
because it has not filed any periodic reports since it filed a Form 10-
SB registration statement on April 24, 1997.
    The Commission is of the opinion that the public interest and the 
protection of investors require a suspension of trading in the 
securities of the above-listed company.
    Therefore, it is ordered, pursuant to section 12(k) of the 
Securities Exchange Act of 1934, that trading in the above-listed 
company is suspended for the period from 9:30 a.m. EDT on June 1, 2006, 
through 11:59 p.m. EDT on June 14, 2006.

    By the Commission.
Nancy M. Morris,
Secretary.
[FR Doc. 06-5128 Filed 6-1-06; 11:37 am]
BILLING CODE 8010-01-P